Floor and Ceiling Effects, Time to Completion, and Question Burden of PROMIS CAT Domains Among Shoulder and Knee Patients Undergoing Nonoperative and Operative Treatment

Abstract

The purpose of this form is to provide readers of your manuscript with information about your other interests that could influence how they receive and understand your work. The form is designed to be completed electronically and stored electronically. It contains programming that allows appropriate data display. Each author should submit a separate form and is responsible for the accuracy and completeness of the submitted information. The form is in six parts. Identifying information. The work under consideration for publication. This section asks for information about the work that you have submitted for publication. The time frame for this reporting is that of the work itself, from the initial conception and planning to the present. The requested information is about resources that you received, either directly or indirectly (via your institution), to enable you to complete the work. Checking "No" means that you did the work without receiving any financial support from any third party-that is, the work was supported by funds from the same institution that pays your salary and that institution did not receive third-party funds with which to pay you. If you or your institution received funds from a third party to support the work, such as a government granting agency, charitable foundation or commercial sponsor, check "Yes". Relevant financial activities outside the submitted work. This section asks about your financial relationships with entities in the bio-medical arena that could be perceived to influence, or that give the appearance of potentially influencing, what you wrote in the submitted work. You should disclose interactions with ANY entity that could be considered broadly relevant to the work. For example, if your article is about testing an epidermal growth factor receptor (EGFR) antagonist in lung cancer, you should report all associations with entities pursuing diagnostic or therapeutic strategies in cancer in general, not just in the area of EGFR or lung cancer. Report all sources of revenue paid (or promised to be paid) directly to you or your institution on your behalf over the 36 months prior to submission of the work. This should include all monies from sources with relevance to the submitted work, not just monies from the entity that sponsored the research. Please note that your interactions with the work's sponsor that are outside the submitted work should also be listed here. If there is any question, it is usually better to disclose a relationship than not to do so. For grants you have received for work outside the submitted work, you should disclose support ONLY from entities that could be perceived to be affected financially by the published work, such as drug companies, or foundations supported by entities that could be perceived to have a financial stake in the outcome. Public funding sources, such as government agencies, charitable foundations or academic institutions, need not be disclosed. For example, if a government agency sponsored a study in which you have been involved and drugs...

Patients Require Less Time to Complete Preoperative Patient-Reported Outcomes Measurement Information System (PROMIS) Than Legacy Patient-Reported Outcome Measures

“…5,6 With the addition of these measures, PROMIS has reduced redundant questions while addressing multiple modalities, therefore reducing the number of responses required to provide an outcome score assessment in comparison with legacy PROs, while providing accurate health state estimations across specialties. 7,8 PROMIS also has been shown to be an effective and efficient tool for reporting patient outcomes in various orthopaedic surgery procedures [9][10][11] and has strongly correlated with common legacy PROs. 12,13 It is well established within the literature that hip arthroscopy is an effective treatment for femoroacetabular impingement syndrome (FAIS) and leads to improvement in PROs over time.…”

Validity, reliability, and ceiling and floor effects of the PROMIS Preference score (PROPr) in patients with rheumatological and psychosomatic conditions

“…Moderate ceiling (floor) effects are defined by > 10%, minor by > 5%, and negligible by < 5% of the sample (35).…”

Investigating the PROMIS Physical Function and Pain Interference Domains in Elite Athletes

“…When functionally impaired knee or shoulder surgery patients were surveyed, 1 study found negligible ceiling and floor effects (<2% for PROMIS-PF and PROMIS-PI). 6 Still, some studies have identified varying levels of ceiling and floor effects for PRO-MIS-CAT in impaired patient populations undergoing orthopaedic procedures. Ceiling effects as great as 28% were identified in patients undergoing upper extremity fracture care, 5 and floor effects as great as 19% were identified in patients undergoing cervical spine surgery.…”